Researchers discovered that dysregulated circadian rhythms cause microglia, the brain’s immune cells, to become “stress-primed” and malfunction. This state prevents them from clearing amyloid plaques, accelerating dementia risk. Now, using DARI seedling grants, Souza is testing a stem-cell-derived “EV therapy” designed to keep these cells healthy and prevent neuroinflammation.
